Skip to main content
. 2015 Aug 28;6(31):31659–31673. doi: 10.18632/oncotarget.5229

Figure 2. SB431542 abolishes activin B-induced cell migration, invasion and adhesion.

Figure 2

Migration A., invasion B. and vitronectin adhesion C. assays were performed with HEC-1B and KLE cells following pre-treatment with vehicle control (DMSO) or SB431542 (10 μM) for 1 h prior to treatment without (Ctrl) or with 50 ng/mL activin B (Act B) for a further 24 h. Results are expressed as the mean ± SEM of at least three independent experiments. Values without a common letter are significantly different (P < 0.05).